Lack of change in glucose metabolism in eszopiclone-treated primary insomnia patients.

about

Hypnotic drug risks of mortality, infection, depression, and cancer: but lack of benefit

P2860

Q26745934-C4F6B5D7-D324-464B-AA37-3D575D478827

P2860

Lack of change in glucose metabolism in eszopiclone-treated primary insomnia patients.

Item

http://www.wikidata.org/entity/Q38372503

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Lack of change in glucose metabolism in eszopiclone-treated primary insomnia patients.

@en

type

Item

label

Lack of change in glucose metabolism in eszopiclone-treated primary insomnia patients.

@en

prefLabel

Lack of change in glucose metabolism in eszopiclone-treated primary insomnia patients.

@en

P1476

Lack of change in glucose metabolism in eszopiclone-treated primary insomnia patients.

@en

P2093

John W Winkelman

http://www.w3.org/2001/XMLSchema#string

Milena K Pavlova

http://www.w3.org/2001/XMLSchema#string

Orfeu M Buxton

http://www.w3.org/2001/XMLSchema#string

Shawn P O'Connor

http://www.w3.org/2001/XMLSchema#string

Wei Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Impact of sleep debt on metabolic and endocrine function

Measuring sleep: accuracy, sensitivity, and specificity of wrist actigraphy compared to polysomnography

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes

Exposure to recurrent sleep restriction in the setting of high caloric intake and physical inactivity results in increased insulin resistance and reduced glucose tolerance

Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption

Sleep disturbances compared to traditional risk factors for diabetes development: Systematic review and meta-analysis.

Sleep restriction for 1 week reduces insulin sensitivity in healthy men.

Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis.

Relation between sleep quality and quantity, quality of life, and risk of developing diabetes in healthy workers in Japan: the High-risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) Study.

A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia

P304

187-198

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/NSS.S130505

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28790874

http://www.w3.org/2001/XMLSchema#string

P921

glycobiology

P932

5530064

http://www.w3.org/2001/XMLSchema#string

Lack of change in glucose metabolism in eszopiclone-treated primary insomnia patients.

about

P2860

P2860

Lack of change in glucose metabolism in eszopiclone-treated primary insomnia patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P698

P921

P932